School of Medicine

Researchers at Washington University School of Medicine have found that multidrug-resistant bacteria and bacterial spores can be killed by ultrashort-pulse lasers. The findings could lead to new ways to sterilize wounds and blood products without damaging human cells.

Stacey Lynn Rentschler at the School of Medicine received a four-year $2 million grant from the National Heart, Lung and Blood Institute of the National Institutes of Health (NIH).

Brian Kim, MD, at the School of Medicine, received a five-year, $2.4 million grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health (NIH) to research skin inflammation.

Urologic oncologist Sam Bhayani, MD, has been named to lead the Division of Urologic Surgery in the Department of Surgery at Washington University School of Medicine.

Researchers at Washington University are receiving one of 19 grant awards that will support data science research and training activities in Africa. The researchers will focus on developing new training programs in health data science in Rwanda.

People taking TNF inhibitors, a kind of immunosuppressive drug used to treat rheumatoid arthritis and other autoimmune conditions, produced a weaker and shorter-lived antibody response after two doses of Pfizer’s COVID-19 vaccine, according to a study from Washington University School of Medicine.

Brian N. Finck, professor of medicine at the School of Medicine, received a four-year $1.7 million grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) for research on nonalcoholic fatty liver disease.

Daniel Kreisel, surgical director of lung transplantation at Washington University School of Medicine and Barnes-Jewish Hospital, is a principal investigator in a clinical trial funded with a $22 million grant from the National Institutes of Health (NIH). The trial aims to reduce lung transplant rejection.

Research from the lab of Deanna Barch shows that youth who indicate they have persistent, distressing psychotic-like episodes show impairment in a variety of areas.

The Brown School, the Institute for Public Health’s Center for Dissemination and Implementation and the School of Medicine’s Infectious Disease Division have launched the Infectious Disease Dissemination and Implementation Science (IDDI) Initiative.